Chinese english Germany Japanese Korea

4-Amino-1,3-dihydro-1-[(6-meth yl-3-pyridinyl) methyl]-6-[(tetrahydro-2H-pyran-4-yl) methoxy]-2H-imidazo[4,5-c]-pyridin-2-one,toll-like receptor (TLR) agonist

4-Amino-1,3-dihydro-1-[(6-meth yl-3-pyridinyl) methyl]-6-[(tetrahydro-2H-pyran-4-yl) methoxy]-2H-imidazo[4,5-c]-pyridin-2-one,toll-like receptor (TLR) agonist Struktur
CAS-Nr.
Englisch Name:
4-Amino-1,3-dihydro-1-[(6-meth yl-3-pyridinyl) methyl]-6-[(tetrahydro-2H-pyran-4-yl) methoxy]-2H-imidazo[4,5-c]-pyridin-2-one,toll-like receptor (TLR) agonist
Synonyma:
4-Amino-1,3-dihydro-1-[(6-meth yl-3-pyridinyl) methyl]-6-[(tetrahydro-2H-pyran-4-yl) methoxy]-2H-imidazo[4,5-c]-pyridin-2-one,toll-like receptor (TLR) agonist
CBNumber:
CB311631623
Summenformel:
Molgewicht:
0
MOL-Datei:
Mol file
Request For Quotation

4-Amino-1,3-dihydro-1-[(6-meth yl-3-pyridinyl) methyl]-6-[(tetrahydro-2H-pyran-4-yl) methoxy]-2H-imidazo[4,5-c]-pyridin-2-one,toll-like receptor (TLR) agonist Eigenschaften

Sicherheit

4-Amino-1,3-dihydro-1-[(6-meth yl-3-pyridinyl) methyl]-6-[(tetrahydro-2H-pyran-4-yl) methoxy]-2H-imidazo[4,5-c]-pyridin-2-one,toll-like receptor (TLR) agonist Chemische Eigenschaften,Einsatz,Produktion Methoden

4-Amino-1,3-dihydro-1-[(6-meth yl-3-pyridinyl) methyl]-6-[(tetrahydro-2H-pyran-4-yl) methoxy]-2H-imidazo[4,5-c]-pyridin-2-one,toll-like receptor (TLR) agonist Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte

4-Amino-1,3-dihydro-1-[(6-meth yl-3-pyridinyl) methyl]-6-[(tetrahydro-2H-pyran-4-yl) methoxy]-2H-imidazo[4,5-c]-pyridin-2-one,toll-like receptor (TLR) agonist Anbieter Lieferant Produzent Hersteller Vertrieb Händler.

Global( 1)Lieferanten
Firmenname Telefon E-Mail Land Produktkatalog Edge Rate
Shanghai meikai technology co., ltd 021-18721550-091 18721550091
 yangdong@pharma.com China 4123 58
  • 4-Amino-1,3-dihydro-1-[(6-meth yl-3-pyridinyl) methyl]-6-[(tetrahydro-2H-pyran-4-yl) methoxy]-2H-imidazo[4,5-c]-pyridin-2-one,toll-like receptor (TLR) agonist
Copyright 2019 © ChemicalBook. All rights reserved